WebDisclosure WebDisclosure
Basculer en Français
10664 Companies
227250 Keywords
155652 Articles
120343 Press releases
Headlines Articles Press releases ABIONYX Remove
  1. Home
  2. Companies
  3. ABIONYX
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 06/13/2024 at 19:53, 2 years ago

    ABIONYX Pharma Receives FDA Approval for New Sepsis Study

    FDA Clinical Study ABIONYX Pharma Sepsis CER-001
  • PRESS RELEASE

    published on 06/13/2024 at 19:48, 2 years ago

    Informations privilégiées / Autres communiqués

    ABIONYX Pharma a passé avec succès la réunion pré-IND avec la FDA pour une étude clinique de phase 2b/3 évaluant CER-001 dans le traitement de patients atteints de sepsis. La société se prépare à déposer une demande d’IND pour lancer l'étude clinique
    FDA ABIONYX Pharma Sepsis CER-001 Réunion Pré-IND
    Logo of ABIONYX
  • PRESS RELEASE

    published on 06/13/2024 at 19:48, 2 years ago

    Inside Information / Other news releases

    ABIONYX Pharma completes successful pre-IND meeting with the FDA for CER-001 Phase 2b/3 Clinical Trial in Sepsis, marking significant progress in developing innovative therapy
    FDA ABIONYX Pharma Sepsis CER-001 Pre-IND Meeting
    Logo of ABIONYX
Previous page
1 ... 16 17
Accesswire
  • Published on 07/01/2026 at 00:00, 24 minutes ago

    Onco-Innovations Initiates Polymer Process Development and Characterization Program for ONC010

  • Published on 06/30/2026 at 23:01, 1 hour 23 minutes ago

    NextSource Materials Provides Clarification on a Prior News Release

  • Published on 06/30/2026 at 22:30, 1 hour 54 minutes ago

    International Battery Metals Announces Change of Auditor

  • Published on 06/30/2026 at 22:12, 2 hours 12 minutes ago

    Gold Terra Announces Filing of Technical Report on the Yellowknife Project, NWT and 2026 Annual General and Special Meeting Results

  • Published on 06/30/2026 at 20:55, 3 hours 29 minutes ago

    Clean Air Metals Files Interim Financial Statements for the Three Months Ended April 30, 2026

View all ACCESSWIRE
EQS Group
  • Published on 06/30/2026 at 22:48, 1 hour 35 minutes ago

    Abivax Announces Launch of Public Offering of American Depositary Shares

  • Published on 06/30/2026 at 22:45, 1 hour 38 minutes ago

    Abivax annonce le lancement d’une offre au public d’American Depositary Shares

  • Published on 06/30/2026 at 21:53, 2 hours 31 minutes ago

    EQS-Adhoc: aconnic AG: announces the prolongation of the existing debt facility and postpones the publication of the financial report 2025 on or before September 30th, 2026

  • Published on 06/30/2026 at 21:00, 3 hours 24 minutes ago

    Europlasma sollicite l’ouverture d’une procédure de redressement judiciaire de sa filiale FDB Industries

  • Published on 06/30/2026 at 20:43, 3 hours 41 minutes ago

    EQS-Adhoc: BayWa AG: Understanding in principle on a concept for adjusting the restructuring agreement with key creditors and major shareholders

View all EQS
Les Echos
  • Published on 06/30/2026 at 20:52, 3 hours 31 minutes ago

    Number of shares and voting rights - May 2026 (In French only)

  • Published on 06/30/2026 at 20:52, 3 hours 31 minutes ago

    Nombre total d'actions et droits de vote - mai 2026

  • Published on 06/30/2026 at 18:59, 5 hours 24 minutes ago

    SUEZ has successfully completed a €600 million green bond issuance

  • Published on 06/30/2026 at 18:56, 5 hours 27 minutes ago

    SUEZ réalise avec succès une émission obligataire verte

  • Published on 06/30/2026 at 18:33, 5 hours 50 minutes ago

    CP de mise à disposition du RA

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy